WBAI [500.com] NT 20-F: (Original Filing)
[]
CHL [CHINA MOBILE] 6-K: (Original Filing)
[Number 1.1 Announcement with respect to Grant of Share Options Under the Share Option Scheme, dated June 12, 2020 • our business objectives and strategies, including those relating to the development of our terminal procurement and distribution business; • our operations and prospects; • our network]
CHL [CHINA MOBILE] 6-K: Number 1.1 Announcement with respect to Grant of
[Number 1.1 Announcement with respect to Grant of Share Options Under the Share Option Scheme, dated June 12, 2020 • our business objectives and strategies, including those relating to the development of our terminal procurement and distribution business; • our operations and prospects; • our network]
CCCL [China Ceramics] EFFECT: (Original Filing)
[.FormData {color: blue; background-color: white; font-size: small; font-family: Times, serif} .SmallFormData {color: blue; background-color: white; font-size: x-small; font-family: Times, serif} .FootnoteData {color: green; background-color: white; font-size: x-small; font-family: Times, serif} .For]
SVA [SINOVAC BIOTECH] 6-K: (Original Filing)
[Sinovac Announces Positive Preliminary Results of Phase I/II Clinical Trials for Inactivated Vaccine Candidate Against COVID-19 Beijing-June 13, 2020 — Sinovac Biotech Ltd. (“Sinovac” or the “ Company”)(Nasdaq: SVA), a leading provider of biopharmaceutical products in China, today announced positive]
CCCL [China Ceramics] EFFECT: .FormData {color: blue; background-color: white; font-size: small; font-family:
[.FormData {color: blue; background-color: white; font-size: small; font-family: Times, serif} .SmallFormData {color: blue; background-color: white; font-size: x-small; font-family: Times, serif} .FootnoteData {color: green; background-color: white; font-size: x-small; font-family: Times, serif} .For]
SVA [SINOVAC BIOTECH] 6-K: Sinovac Announces Positive Preliminary Results of Phase I/II
[Sinovac Announces Positive Preliminary Results of Phase I/II Clinical Trials for Inactivated Vaccine Candidate Against COVID-19 Beijing-June 13, 2020 — Sinovac Biotech Ltd. (“Sinovac” or the “ Company”)(Nasdaq: SVA), a leading provider of biopharmaceutical products in China, today announced positive]
CXDC [China XD Plastics Co] SC 13D/A: (Original Filing)
[EQUITY CONTRIBUTION and voting AGREEMENT Agreement This EQUITY CONTRIBUTION AND VOTING AGREEMENT (this “ Parent Company Schedule A Rollover Stockholder Rollover Stockholders RECITALS Merger Sub Merger Agreement Merger WHEREAS, concurrently herewith, Parent, Faith Horizon Inc., a Nevada corporation a]
SGOC [SGOCO] 20-F: (Original Filing)
[] [List of Subsidiaries Name of Subsidiary Jurisdiction of Formation SGOCO International (HK) Limited Hong Kong Beijing SGOCO Image Technology Co., Ltd. People’s Republic of China SGO Corporation. Delaware, USA Boca International Limited Hong Kong Vision Lane Limited British Virgin Islands First Asi]
